THE EFFECT OF DURATION OF ACETYLCHOLINE-ESTERASE INHIBITOR ON MMSE, CDT AND BARTHEL INDEX SCORING ON PATIENTS WITH VASCULAR DEMENSIA

Background: Vascular dementia is a cognitive decline with functional deterioration caused by cerebrovascular disease. It is the second leading cause of dementia. A number of screening questionnaires and models have been developed to help in assessing cognitive function and activity daily living (ADL...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sri Budhi Rianawati, Ria Damayanti, Harun Al Rasyid, Nyoman Artha Megayasa
Formato:	article
Lenguaje:	EN ID
Publicado:	University of Brawijaya 2021
Materias:	vascular dementia mmse cdt barthel index acetylcholine-esterase inhibitor Medicine R Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/b935f2f5a3514afab61966427f54ee6a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b935f2f5a3514afab61966427f54ee6a
record_format	dspace
spelling	oai:doaj.org-article:b935f2f5a3514afab61966427f54ee6a2021-11-24T05:18:08ZTHE EFFECT OF DURATION OF ACETYLCHOLINE-ESTERASE INHIBITOR ON MMSE, CDT AND BARTHEL INDEX SCORING ON PATIENTS WITH VASCULAR DEMENSIA10.21776/ub.mnj.2021.007.02.42407-67242442-5001https://doaj.org/article/b935f2f5a3514afab61966427f54ee6a2021-07-01T00:00:00Zhttps://mnj.ub.ac.id/index.php/mnj/article/view/490https://doaj.org/toc/2407-6724https://doaj.org/toc/2442-5001Background: Vascular dementia is a cognitive decline with functional deterioration caused by cerebrovascular disease. It is the second leading cause of dementia. A number of screening questionnaires and models have been developed to help in assessing cognitive function and activity daily living (ADL) in patients with dementia. Mini Mental State Examination (MMSE), Clock Drawing Test (CDT) and Barthel Index are instruments to evaluate cognitive function and ADL of vascular dementia patients. Objective: To determine the role of achetylcholine-esterase inhibitor therapy on cognitive function and ADL in patients with vascular dementia in Saiful Anwar General Hospital. Methods: This study is an analytical study assessing the improvement of cognitive function and ADL of patients with vascular dementia after administration of acethylcholine-esterase inhibitor by assessing the MMSE, CDT and Barthel Index scoring in 1, 3, 6 and 12 month period consecutively. Results: From 15 study subjects, individuals who have been given treatment for 12 months consecutively have the highest increase in MMSE and CDT whilst for Barthel Index has shown highest improvement in one month period. Conclusion: The administration of acetylcholine-esterase inhibitor drugs has the potential to improve and maintain cognitive function and improve ADL. The limited number of study subjects and the many confounding factors that we did not evaluate were the drawbacks of this study. The results of this study cannot be generalized to all patients with vascular dementia and only apply to 15 patients who were the subjects of this study. Sri Budhi RianawatiRia DamayantiHarun Al RasyidNyoman Artha MegayasaUniversity of Brawijayaarticlevascular dementiammsecdtbarthel indexacetylcholine-esterase inhibitorMedicineRNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENIDMalang Neurology Journal, Vol 7, Iss 2, Pp 104-108 (2021)
institution	DOAJ
collection	DOAJ
language	EN ID
topic	vascular dementia mmse cdt barthel index acetylcholine-esterase inhibitor Medicine R Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
spellingShingle	vascular dementia mmse cdt barthel index acetylcholine-esterase inhibitor Medicine R Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Sri Budhi Rianawati Ria Damayanti Harun Al Rasyid Nyoman Artha Megayasa THE EFFECT OF DURATION OF ACETYLCHOLINE-ESTERASE INHIBITOR ON MMSE, CDT AND BARTHEL INDEX SCORING ON PATIENTS WITH VASCULAR DEMENSIA
description	Background: Vascular dementia is a cognitive decline with functional deterioration caused by cerebrovascular disease. It is the second leading cause of dementia. A number of screening questionnaires and models have been developed to help in assessing cognitive function and activity daily living (ADL) in patients with dementia. Mini Mental State Examination (MMSE), Clock Drawing Test (CDT) and Barthel Index are instruments to evaluate cognitive function and ADL of vascular dementia patients. Objective: To determine the role of achetylcholine-esterase inhibitor therapy on cognitive function and ADL in patients with vascular dementia in Saiful Anwar General Hospital. Methods: This study is an analytical study assessing the improvement of cognitive function and ADL of patients with vascular dementia after administration of acethylcholine-esterase inhibitor by assessing the MMSE, CDT and Barthel Index scoring in 1, 3, 6 and 12 month period consecutively. Results: From 15 study subjects, individuals who have been given treatment for 12 months consecutively have the highest increase in MMSE and CDT whilst for Barthel Index has shown highest improvement in one month period. Conclusion: The administration of acetylcholine-esterase inhibitor drugs has the potential to improve and maintain cognitive function and improve ADL. The limited number of study subjects and the many confounding factors that we did not evaluate were the drawbacks of this study. The results of this study cannot be generalized to all patients with vascular dementia and only apply to 15 patients who were the subjects of this study.
format	article
author	Sri Budhi Rianawati Ria Damayanti Harun Al Rasyid Nyoman Artha Megayasa
author_facet	Sri Budhi Rianawati Ria Damayanti Harun Al Rasyid Nyoman Artha Megayasa
author_sort	Sri Budhi Rianawati
title	THE EFFECT OF DURATION OF ACETYLCHOLINE-ESTERASE INHIBITOR ON MMSE, CDT AND BARTHEL INDEX SCORING ON PATIENTS WITH VASCULAR DEMENSIA
title_short	THE EFFECT OF DURATION OF ACETYLCHOLINE-ESTERASE INHIBITOR ON MMSE, CDT AND BARTHEL INDEX SCORING ON PATIENTS WITH VASCULAR DEMENSIA
title_full	THE EFFECT OF DURATION OF ACETYLCHOLINE-ESTERASE INHIBITOR ON MMSE, CDT AND BARTHEL INDEX SCORING ON PATIENTS WITH VASCULAR DEMENSIA
title_fullStr	THE EFFECT OF DURATION OF ACETYLCHOLINE-ESTERASE INHIBITOR ON MMSE, CDT AND BARTHEL INDEX SCORING ON PATIENTS WITH VASCULAR DEMENSIA
title_full_unstemmed	THE EFFECT OF DURATION OF ACETYLCHOLINE-ESTERASE INHIBITOR ON MMSE, CDT AND BARTHEL INDEX SCORING ON PATIENTS WITH VASCULAR DEMENSIA
title_sort	effect of duration of acetylcholine-esterase inhibitor on mmse, cdt and barthel index scoring on patients with vascular demensia
publisher	University of Brawijaya
publishDate	2021
url	https://doaj.org/article/b935f2f5a3514afab61966427f54ee6a
work_keys_str_mv	AT sribudhirianawati theeffectofdurationofacetylcholineesteraseinhibitoronmmsecdtandbarthelindexscoringonpatientswithvasculardemensia AT riadamayanti theeffectofdurationofacetylcholineesteraseinhibitoronmmsecdtandbarthelindexscoringonpatientswithvasculardemensia AT harunalrasyid theeffectofdurationofacetylcholineesteraseinhibitoronmmsecdtandbarthelindexscoringonpatientswithvasculardemensia AT nyomanarthamegayasa theeffectofdurationofacetylcholineesteraseinhibitoronmmsecdtandbarthelindexscoringonpatientswithvasculardemensia AT sribudhirianawati effectofdurationofacetylcholineesteraseinhibitoronmmsecdtandbarthelindexscoringonpatientswithvasculardemensia AT riadamayanti effectofdurationofacetylcholineesteraseinhibitoronmmsecdtandbarthelindexscoringonpatientswithvasculardemensia AT harunalrasyid effectofdurationofacetylcholineesteraseinhibitoronmmsecdtandbarthelindexscoringonpatientswithvasculardemensia AT nyomanarthamegayasa effectofdurationofacetylcholineesteraseinhibitoronmmsecdtandbarthelindexscoringonpatientswithvasculardemensia
_version_	1718415936805928960

THE EFFECT OF DURATION OF ACETYLCHOLINE-ESTERASE INHIBITOR ON MMSE, CDT AND BARTHEL INDEX SCORING ON PATIENTS WITH VASCULAR DEMENSIA

Ejemplares similares